Last updated on February 2018

Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain


Brief description of study

The objective of this study is to verify the superiority of 16 weeks of MT-5547 treatment to placebo, as evidenced by the WOMAC pain score (the efficacy outcome measure), in patients with osteoarthritis of the knee or hip. Additional objectives of the study are to investigate the efficacy, safety, and pharmacokinetics of MT-5547 in long-term use.

Detailed Study Description

The blind will be maintained, including for the study sponsor, until the key code is opened after the data have been fixed for all subjects in Week 24. In addition, in order to eliminate any bias that could affect the study assessments, to the extent possible, the blind will be maintained with respect to the study site and the subject even after the opening of the study sponsor key code.

Clinical Study Identifier: NCT03245008

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Information Desk, to ...

Investigational Site
Shiga, Japan
1.22miles
  Connect »

Clinical Trials Information Desk, to ...

Investigational Site
Kyoto, Japan
4.92miles
  Connect »